The Korea Herald

지나쌤

Intron Biotech inks trust contract for W1.5b repurchase

By KH디지털2

Published : Aug. 31, 2016 - 11:00

    • Link copied

[DISCLOSURE] Intron Biotechnology (048530) said on Aug. 31 that it has signed a trust contract with Hyundai Securities to repurchase up to 1.5 billion won (US$1.3 million) of its stock to stabilize its stock value and boost shareholder value. 

The contract expires Aug. 30, 2017.

By Jung Min-kyung (mkj1105@heraldcorp.com)